9C7-92897-23483 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-02
Dose 1 — Pfizer-BioNTech
2021-09-03
Registered in v-safe
2021-09-03
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches · Be unable to work or attend school

Adult check-in
2021-09-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-09-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-10
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-09-18
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-09-27
Dose 2 — Pfizer-BioNTech
2021-09-27
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-09-28
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Dyspnoea — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Free text: Shortness of breath, weakness

MedDRA releases: 2024-11 · check-in free text available
2021-09-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-10-13
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-08
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-03-30
Survey response — 6 months, dose 2
MedDRA: Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: I developed pre-eclampsia during pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-03-30
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-03-31
Call 1 — Left Voicemail
2022-09-29
Survey response — 12 months, dose 2
MedDRA: Fatigue, Parosmia — Feeling: Fair

Free text: General fatigue, still having phantom smells and smell aversions.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-02	Pfizer-BioNTech	No
2	2021-09-27	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 2

2021-09-28

Systemic reaction (other): Shortness of breath, weakness

Release 11 — 6 months, dose 2

2022-03-30

Symptoms: I developed pre-eclampsia during pregnancy

Release 12 — 12 months, dose 2

2022-09-29

Symptoms: General fatigue, still having phantom smells and smell aversions.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Parosmia	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Asthenia	·	·	✓
SRO	Dyspnoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release